Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2024-05-10 00:00:00 ET · period of report 2024-05-08 · accession 0001104659-24-060003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-10 | 2024-05-08 | OBIO | Papandreou George | See Remarks | A - Grant | $0.00 | +22.0K | 42.0K | +110% | $0 |
| D | 2024-05-10 | 2024-05-08 | OBIO | Papandreou George | See Remarks | A - Grant | $0.00 | +33.0K | 33.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share ("Common Stock") | 2024-05-08 | A | A | 22,000 | $0.00 | 42,000 | D | — | — | (F1) Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (i) 3,300 RSUs will vest on May 22, 2025, and (ii) the remaining 18,700 RSUs will vest in equal installments on August 22, 2025, November 22, 2025, December 24, 2025, May 22, 2026, August 22, 2026, November 22, 2026, March 25, 2027, May 22, 2027, August 22, 2027, November 22, 2027, March 25, 2028 and May 22, 2028, subject to the Reporting Person's continuous service through such dates. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-05-08 | A | A | 33,000 | $0.00 | 33,000 | D | $4.98 · — to 2034-05-08 | — Common Stock | (F2) The stock options will vest as follows: (i) 8,250 of the stock options will vest on May 8, 2025 (the "Vesting Date") and (ii) the remaining 24,750 of the stock options will vest in equal installments every three months on the same day of the month as the Vesting Date, starting on August 8, 2025, subject to the Reporting Person's continuous service through such dates. |